ABNX — Abionyx Pharma SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Abionyx Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	7.93	4.05	4.1	3.23	3.52
Net Total Accounts Receivable
Net Total Receivables	4.62	3.05	2.5	2.29	1.59
Total Inventory
Prepaid Expenses
Total Current Assets	13	7.57	6.89	5.86	5.47
Net Property, Plant And Equipment	3.07	2.56	2.21	1.98	1.8
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	21.8	15.8	14.8	13.5	13.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6.75	5.09	3.92	3.71	5.16
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.2	8.65	6.91	6.03	8.6
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	10.7	7.17	7.92	7.51	4.51
Total Liabilities & Shareholders' Equity	21.8	15.8	14.8	13.5	13.1
Total Common Shares Outstanding